The Motley Fool

Rhys Brock

Rhys Brock has been a Motley Fool contributor since late 2017. Originally a literature graduate with a passion for writing, his travels took him to the United Kingdom and the Cayman Islands, where he made ends meet working administrative jobs in banking and hedge fund administration. This exposure to the global finance industry uncovered a fascination with international markets and investing. Now back in Australia, and having passed all three levels of the CFA Program, Rhys is keen to share his passion for investing with Motley Fool readers.

These 3 ASX healthcare shares could make you rich

Here are 3 ASX healthcare shares looking to carve out their own niches – and in doing so, might even grow into tomorrow’s CSL... More »

3 ASX growth shares for your portfolio in 2020

With the coronavirus outbreak sending the share prices of many market darlings tumbling, here are three other ASX growth stocks that could still take... More »

3 ASX healthcare growth shares to add to your 2020 watchlist

Here are 3 companies that, while still speculative and risky in nature, have the potential to grow into tomorrow’s ASX healthcare blue chips. More »

Could this be the best ASX healthcare stock in 2020?

The Polynovo Limited (ASX: PNV) share price is up over 300% in just 12 months. But this could still be just the beginning of... More »

Where I’d invest $10,000 in a volatile 2020

Although the ASX has started the year strongly, 2020 still has the potential for negative surprises. Here's where I’d invest $10,000 to insure my... More »

Why the LiveTiles share price has skyrocketed 40% in a week

The LiveTiles Ltd (ASX: LVT) share price surged 40% higher last week after announcing strong quarterly results and a new agreement with the US... More »

Paradigm Biopharmaceuticals shares have skyrocketed. Should you invest?

The share price of ASX biotech company Paradigm Biopharmaceuticals Ltd (ASX: PAR) has surged over 250% in the last 12 months. Here’s why you... More »

Why this growing ASX healthcare company should be on everyone’s watch lists

Shares of emerging biotechnology company Opthea Ltd (ASX: OPT) have more than quadrupled in price since August last year. More »

This ASX healthcare share skyrocketed last week. Should you invest?

The share price of growing healthcare company Medical Developments International Limited (ASX: MVP) is up over 130% since September. Here’s why it should be... More »

Why the Pilbara Minerals share price is up 50% since December

The share price of Pilbara Minerals Limited (ASX:PLS) is up 50% since December. But is an investment in this pureplay lithium miner worth the... More »

3 ASX shares for the ethical investor

Here are three ASX options for those seeking to be more environmentally and socially conscious about where they invest their money. More »

The EML Payments share price skyrocketed 200% in 2019. Could 2020 be even better?

Despite its shares surging over 200% higher in 2019, I think the best may still be yet to come for payments provider EML Payments... More »

3 ASX companies to watch in 2020

These 3 ASX companies that have already laid solid foundations for future growth – so much so that 2020 might even end up being... More »

3 ASX growth shares that could become tomorrow’s blue-chips

If you’ve decided 2020 will be the year you finally start building your share portfolio, here are my three picks for ASX growth stocks... More »